Get our free extension to see links to code for papers anywhere online!

Chrome logo Add to Chrome

Firefox logo Add to Firefox
Picture for Tom Brettin

Tom Brettin

Pandemic Drugs at Pandemic Speed: Accelerating COVID-19 Drug Discovery with Hybrid Machine Learning- and Physics-based Simulations on High Performance Computers


Mar 04, 2021
Agastya P. Bhati, Shunzhou Wan, Dario Alfè, Austin R. Clyde, Mathis Bode, Li Tan, Mikhail Titov, Andre Merzky, Matteo Turilli, Shantenu Jha, Roger R. Highfield, Walter Rocchia, Nicola Scafuri, Sauro Succi, Dieter Kranzlmüller, Gerald Mathias, David Wifling, Yann Donon, Alberto Di Meglio, Sofia Vallecorsa, Heng Ma, Anda Trifan, Arvind Ramanathan, Tom Brettin, Alexander Partin, Fangfang Xia, Xiaotan Duan, Rick Stevens, Peter V. Coveney

Figure 1 for Pandemic Drugs at Pandemic Speed: Accelerating COVID-19 Drug Discovery with Hybrid Machine Learning- and Physics-based Simulations on High Performance Computers
Figure 2 for Pandemic Drugs at Pandemic Speed: Accelerating COVID-19 Drug Discovery with Hybrid Machine Learning- and Physics-based Simulations on High Performance Computers
Figure 3 for Pandemic Drugs at Pandemic Speed: Accelerating COVID-19 Drug Discovery with Hybrid Machine Learning- and Physics-based Simulations on High Performance Computers
Figure 4 for Pandemic Drugs at Pandemic Speed: Accelerating COVID-19 Drug Discovery with Hybrid Machine Learning- and Physics-based Simulations on High Performance Computers

  Access Paper or Ask Questions

Targeting SARS-CoV-2 with AI- and HPC-enabled Lead Generation: A First Data Release


May 28, 2020
Yadu Babuji, Ben Blaiszik, Tom Brettin, Kyle Chard, Ryan Chard, Austin Clyde, Ian Foster, Zhi Hong, Shantenu Jha, Zhuozhao Li, Xuefeng Liu, Arvind Ramanathan, Yi Ren, Nicholaus Saint, Marcus Schwarting, Rick Stevens, Hubertus van Dam, Rick Wagner

Figure 1 for Targeting SARS-CoV-2 with AI- and HPC-enabled Lead Generation: A First Data Release
Figure 2 for Targeting SARS-CoV-2 with AI- and HPC-enabled Lead Generation: A First Data Release
Figure 3 for Targeting SARS-CoV-2 with AI- and HPC-enabled Lead Generation: A First Data Release
Figure 4 for Targeting SARS-CoV-2 with AI- and HPC-enabled Lead Generation: A First Data Release
* 11 pages, 5 figures 
  Access Paper or Ask Questions

A Systematic Approach to Featurization for Cancer Drug Sensitivity Predictions with Deep Learning


May 04, 2020
Austin Clyde, Tom Brettin, Alexander Partin, Maulik Shaulik, Hyunseung Yoo, Yvonne Evrard, Yitan Zhu, Fangfang Xia, Rick Stevens

Figure 1 for A Systematic Approach to Featurization for Cancer Drug Sensitivity Predictions with Deep Learning
Figure 2 for A Systematic Approach to Featurization for Cancer Drug Sensitivity Predictions with Deep Learning
Figure 3 for A Systematic Approach to Featurization for Cancer Drug Sensitivity Predictions with Deep Learning
Figure 4 for A Systematic Approach to Featurization for Cancer Drug Sensitivity Predictions with Deep Learning

  Access Paper or Ask Questions

Scalable Reinforcement-Learning-Based Neural Architecture Search for Cancer Deep Learning Research


Sep 01, 2019
Prasanna Balaprakash, Romain Egele, Misha Salim, Stefan Wild, Venkatram Vishwanath, Fangfang Xia, Tom Brettin, Rick Stevens

Figure 1 for Scalable Reinforcement-Learning-Based Neural Architecture Search for Cancer Deep Learning Research
Figure 2 for Scalable Reinforcement-Learning-Based Neural Architecture Search for Cancer Deep Learning Research
Figure 3 for Scalable Reinforcement-Learning-Based Neural Architecture Search for Cancer Deep Learning Research
Figure 4 for Scalable Reinforcement-Learning-Based Neural Architecture Search for Cancer Deep Learning Research
* SC '19: IEEE/ACM International Conference on High Performance Computing, Networking, Storage and Analysis, November 17--22, 2019, Denver, CO 
  Access Paper or Ask Questions